Article
Author(s):
A research team led by Johns Hopkins Bloomberg School of Public Health investigators has issued a report to help tackle the prescription opioid epidemic that kills an average of 44 people per day in the United States.
A research team led by Johns Hopkins Bloomberg School of Public Health investigators has issued a report to help tackle the prescription opioid epidemic that kills an average of 44 people per day in the United States.
Stemming from discussions at a town hall meeting co-hosted by the Bloomberg School and the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, the report recommends changes in the following:
Recommendations were developed with the input of professionals from medicine, pharmacy, injury prevention, law, insurance, and patient representatives.
“What’s important about these recommendations is that they cover the entire supply chain, from training doctors to working with pharmacies and the pharmaceuticals themselves, as well as reducing demand by mobilizing communities and treating people addicted to opioids,” said Andrea Gielen, ScD, ScM, director of the Johns Hopkins Center for Injury Research and Policy at the Bloomberg School and one of the report's signatories. “Not only are the recommendations comprehensive, they were developed with input from a wide range of stakeholders, and wherever possible draw from evidence-based research.”
The report comes at an opportune time, as opioid doses are at an all-time high. According to the Centers for Disease Control and Prevention (CDC), opioid overdose-related deaths grew four times between 1999 and 2013, up to 16,000. During the same period, prescription opioid sales increased 300%. The CDC estimated that 2 million Americans were dependent on opioids in 2013. In 2012, 259 million prescriptions were written for opioids, enough to supply every American adult with a non-stop, 4-weeks supply, according to the CDC.
Titled “The Prescription Opioid Epidemic: An Evidence-Based Approach,” the report includes seven sections of recommendations:
In regard to PDMPs—state databases including controlled substance prescriptions from in-state pharmacies—the report authors call for mandatory use, as PDMPs are voluntary in many states and actual use and designs vary from state to state. The report also recommends that PDMPs be more accessible to law enforcement as warranted.
Other recommendations include expanding the availability of naloxone—a medication shown to reverse the effects of an opioid overdose when administered promptly—and the development of more secure and tamper-resistance packaging through design contests and other approaches.
“This is a complex epidemic with no simple solutions,” said G. Caleb Alexander, MD, MS, co-director of the Johns Hopkins Center for Drug Safety and Effectiveness at the Bloomberg School and another of the report’s signatories. “We tried to identify as many windows as possible and to tie together as much research as available to inform these recommendations, which together we believe provide the best chance of turning this steamship around.”